CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,202 | -32.0% | 33,287 | +17.9% | 0.01% | -40.0% |
| Q1 2023 | $138,604 | +207.6% | 28,229 | +572.9% | 0.01% | +233.3% |
| Q4 2022 | $45,054 | +60.9% | 4,195 | +79.9% | 0.00% | +50.0% |
| Q1 2022 | $28,000 | -82.5% | 2,332 | -82.3% | 0.00% | -84.6% |
| Q4 2021 | $160,000 | +416.1% | 13,146 | +497.8% | 0.01% | +550.0% |
| Q2 2021 | $31,000 | -53.0% | 2,199 | -28.2% | 0.00% | -66.7% |
| Q1 2021 | $66,000 | +6500.0% | 3,062 | +3982.7% | 0.01% | – |
| Q4 2020 | $1,000 | -96.0% | 75 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $25,000 | -83.9% | 1,970 | -79.6% | 0.00% | -80.0% |
| Q4 2019 | $155,000 | +109.5% | 9,659 | +147.8% | 0.02% | +200.0% |
| Q2 2018 | $74,000 | +469.2% | 3,898 | +294.5% | 0.01% | +400.0% |
| Q3 2017 | $13,000 | -89.5% | 988 | -85.4% | 0.00% | -92.3% |
| Q1 2017 | $124,000 | +490.5% | 6,783 | +94.9% | 0.01% | +333.3% |
| Q1 2016 | $21,000 | – | 3,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |